Influenza Diagnostics Global Market Opportunities And Strategies To 2031
Description
Influenza Diagnostics Global Market Opportunities And Strategies To 2031
Influenza Diagnostics Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Where is the largest and fastest growing market for influenza diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider influenza diagnostics market; and compares it with other markets.
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – This section gives the segmentation of the influenza diagnostics market by geography, by traditional diagnostic tests, by molecular diagnostic tests and by end user covered in this report.
Market Characteristics – The market characteristics section of the report defines and explains influenza diagnostics market. This chapter also defines and describes goods and related services covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global influenza diagnostics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Impact of COVID-19 – This section describes the impact of COVID-19 on the influenza diagnostics market.
Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026, 2031) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2016-2021), forecast (2021-2026, 2031) market value and growth and market share comparison by region.
Segmentation – This section contains the market values (2016-2021, 2021-2026, 2031) and analysis for different segments in the market.
Regional Market Size and Growth – This section contains the region’s market size (2021), historic and forecast (2021-2026, 2031) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
Competitive Landscape – This section covers details on the competitive landscape of the global influenza diagnostics market, estimated market shares and company profiles for the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for influenza diagnostics providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostics Tests (RIDT); Viral Culture; DFA; Serological Assays; Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Quidel Corp
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Influenza Diagnostics Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest growing market for influenza diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider influenza diagnostics market; and compares it with other markets.
The report covers the following chapters
Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – This section gives the segmentation of the influenza diagnostics market by geography, by traditional diagnostic tests, by molecular diagnostic tests and by end user covered in this report.
Market Characteristics – The market characteristics section of the report defines and explains influenza diagnostics market. This chapter also defines and describes goods and related services covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global influenza diagnostics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Impact of COVID-19 – This section describes the impact of COVID-19 on the influenza diagnostics market.
Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026, 2031) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
Regional Analysis – This section contains the historic (2016-2021), forecast (2021-2026, 2031) market value and growth and market share comparison by region.
Segmentation – This section contains the market values (2016-2021, 2021-2026, 2031) and analysis for different segments in the market.
Regional Market Size and Growth – This section contains the region’s market size (2021), historic and forecast (2021-2026, 2031) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
Competitive Landscape – This section covers details on the competitive landscape of the global influenza diagnostics market, estimated market shares and company profiles for the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for influenza diagnostics providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered: 1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostics Tests (RIDT); Viral Culture; DFA; Serological Assays; Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Quidel Corp
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
303 Pages
- 1. Influenza Diagnostics Market Executive Summary
- 2. Table of Contents
- 3. List of Figures
- 4. List of Tables
- 5. Report Structure
- 6. Introduction
- 6.1.1. Segmentation By Geography
- 6.1.2. Segmentation By Traditional Diagnostic Tests
- 6.1.3. Segmentation By Molecular Diagnostic Tests
- 6.1.4. Segmentation By End-User
- 7. Influenza Diagnostics Market Characteristics
- 7.1. Market Definition
- 7.2. Segmentation By Traditional Diagnostic Tests
- 7.2.1. Rapid Influenza Diagnostic Tests (RIDT)
- 7.2.2. Viral Culture
- 7.2.3. DFA
- 7.2.4. Serological Assays
- 7.2.5. Others
- 7.3. Segmentation By Molecular Diagnostic Tests
- 7.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
- 7.3.2. Isothermal Nucleic Acid Amplification Test
- 7.3.3. Loop-Mediated Isothermal Based Amplification Assays (LAMP)
- 7.3.4. Transcription Mediated Isothermal Based Amplification Assays
- 7.3.5. Other Isothermal Nucleic Acid Amplification Tests
- 7.4. Segmentation By End User
- 7.4.1. Hospitals and Clinical Laboratories
- 7.4.2. Diagnostic Reference Laboratories
- 7.4.3. Academic/Research Institutes
- 7.4.4. Others
- 8. Influenza Diagnostics Market Trends And Strategies
- 8.1. Strategic Partnerships and Acquisitions
- 8.2. Use Of Artificial Intelligence
- 8.3. Collaborations Between Governments And Manufacturers
- 8.4. At-Home Test Kits
- 8.5. Supportive Government Funding and Initiatives
- 9. Impact Of COVID-19 On Influenza Diagnostics Market
- 9.1. Introduction
- 9.2. Impact on Influenza Diagnostic Testing
- 9.3. Promotion Of Flu Vaccination During The COVID-19 Pandemic
- 9.4. Impact On Companies Revenue
- 9.5. Future Outlook
- 10. Global Influenza Diagnostics Market Size And Growth
- 10.1. Market Size
- 10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)
- 10.2.1. Drivers Of The Market 2016 – 2021
- 10.2.2. Restraints On The Market 2016 – 2021
- 10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 10.3.1. Drivers Of The Market 2021 – 2026
- 10.3.2. Restraints On The Market 2021 – 2026
- 11. Global Influenza Diagnostics Market Segmentation
- 11.1. Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.2. Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 11.3. Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12. Influenza Diagnostics Market, Regional And Country Analysis
- 12.1. Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 12.2. Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13. Asia-Pacific Influenza Diagnostics Market
- 13.1. Asia-Pacific Influenza Diagnostics Market Overview
- 13.1.1. Region Information
- 13.1.2. Market Information
- 13.1.3. Background Information
- 13.1.4. Government Initiatives
- 13.1.5. Regulations
- 13.1.6. Regulatory Bodies
- 13.1.7. Major Associations
- 13.1.8. Taxes Levied
- 13.1.9. Corporate Tax Structure
- 13.1.10. Investments
- 13.1.11. Major Companies
- 13.2. Asia-Pacific Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.3. Asia-Pacific Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.4. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.5. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.6. China Influenza Diagnostics Market
- 13.7. China Influenza Diagnostics Market Overview
- 13.7.1. Country Information
- 13.7.2. Market Information
- 13.7.3. Background Information
- 13.7.4. Government Initiatives
- 13.7.5. Regulations
- 13.7.6. Regulatory Bodies
- 13.7.7. Major Associations
- 13.7.8. Taxes Levied
- 13.7.9. Corporate Tax Structure
- 13.7.10. Investments
- 13.7.11. Major Companies
- 13.8. China Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.9. China Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.10. China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.11. China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.12. India Influenza Diagnostics Market
- 13.13. India Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.14. India Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.15. India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.16. India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.17. Japan Influenza Diagnostics Market
- 13.18. Japan Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.19. Japan Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.20. Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.21. Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.22. Australia Influenza Diagnostics Market
- 13.23. Australia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.24. Australia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.25. Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.26. Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.27. Indonesia Influenza Diagnostics Market
- 13.28. Indonesia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.29. Indonesia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.30. Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.31. Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.32. South Korea Influenza Diagnostics Market
- 13.33. South Korea Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 13.34. South Korea Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 13.35. South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 13.36. South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14. Western Europe Influenza Diagnostics Market
- 14.1. Western Europe Influenza Diagnostics Market Overview
- 14.1.1. Region Information
- 14.1.2. Market Information
- 14.1.3. Background Information
- 14.1.4. Government Initiatives
- 14.1.5. Regulations
- 14.1.6. Regulatory Bodies
- 14.1.7. Major Associations
- 14.1.8. Taxes Levied
- 14.1.9. Corporate Tax Structure
- 14.1.10. Investments
- 14.1.11. Major Companies
- 14.2. Western Europe Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 14.3. Western Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 14.4. Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.5. Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.6. Western Europe Influenza Diagnostics Market: Country Analysis
- 14.7. UK Influenza Diagnostics Market
- 14.8. UK Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 14.9. UK Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 14.10. UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.11. UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.12. Germany Influenza Diagnostics Market
- 14.13. Germany Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 14.14. Germany Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 14.15. Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.16. Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.17. France Influenza Diagnostics Market
- 14.18. France Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 14.19. France Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 14.20. France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 14.21. France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15. Eastern Europe Influenza Diagnostics Market
- 15.1. Eastern Europe Influenza Diagnostics Market Overview
- 15.1.1. Region Information
- 15.1.2. Market Information
- 15.1.3. Background Information
- 15.1.4. Government Initiatives
- 15.1.5. Regulations
- 15.1.6. Regulatory Bodies
- 15.1.7. Major Associations
- 15.1.8. Taxes Levied
- 15.1.9. Corporate Tax Structure
- 15.1.10. Investments
- 15.1.11. Major Companies
- 15.2. Eastern Europe Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 15.3. Eastern Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 15.4. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15.5. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15.6. Eastern Europe Influenza Diagnostics Market: Country Analysis
- 15.7. Russia Influenza Diagnostics Market
- 15.8. Russia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 15.9. Russia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 15.10. Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 15.11. Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 16. North America Influenza Diagnostics Market
- 16.1. North America Influenza Diagnostics Market Overview
- 16.1.1. Region Information
- 16.1.2. Market Information
- 16.1.3. Background Information
- 16.1.4. Government Initiatives
- 16.1.5. Regulatory Bodies
- 16.1.6. Regulations
- 16.1.7. Major Associations
- 16.1.8. Taxes Levied
- 16.1.9. Corporate tax structure
- 16.1.10. Investments
- 16.1.11. Major Companies
- 16.2. North America Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 16.3. North America Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 16.4. North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 16.5. North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 16.6. USA Influenza Diagnostics Market
- 16.7. USA Influenza Diagnostics Market Overview
- 16.7.1. Country Information
- 16.7.2. Market Information
- 16.7.3. Background Information
- 16.7.4. Government Initiatives
- 16.7.5. Regulatory Bodies
- 16.7.6. Regulations
- 16.7.7. Major Associations
- 16.7.8. Taxes Levied
- 16.7.9. Corporate Tax Structure
- 16.7.10. Investments
- 16.7.11. Major Companies
- 16.8. USA Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 16.9. USA Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 16.10. USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 16.11. USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 17. South America Influenza Diagnostics Market
- 17.1. South America Influenza Diagnostics Market Overview
- 17.1.1. Region Information
- 17.1.2. Market Information
- 17.1.3. Background Information
- 17.1.4. Government Initiatives
- 17.1.5. Regulations
- 17.1.6. Regulatory Bodies
- 17.1.7. Major Associations
- 17.1.8. Taxes Levied
- 17.1.9. Corporate Tax Structure
- 17.1.10. Investments
- 17.1.11. Major Companies
- 17.2. South America Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 17.3. South America Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 17.4. South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 17.5. South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 17.6. South America Influenza Diagnostics Market: Country Analysis
- 17.7. Brazil Influenza Diagnostics Market
- 17.8. Brazil Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 17.9. Brazil Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 17.10. Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 17.11. Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 18. Middle East Influenza Diagnostics Market
- 18.1. Middle East Influenza Diagnostics Market Overview
- 18.1.1. Region Information
- 18.1.2. Market Information
- 18.1.3. Background Information
- 18.1.4. Government Initiatives
- 18.1.5. Regulations
- 18.1.6. Regulatory Bodies
- 18.1.7. Major Associations
- 18.1.8. Taxes Levied
- 18.1.9. Corporate Tax Structure
- 18.1.10. Investments
- 18.1.11. Major Companies
- 18.2. Middle East Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 18.3. Middle East Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 18.4. Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 18.5. Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 19. Africa Influenza Diagnostics Market
- 19.1. Africa Influenza Diagnostics Market Overview
- 19.1.1. Region Information
- 19.1.2. Market Information
- 19.1.3. Background Information
- 19.1.4. Government Initiatives
- 19.1.5. Regulations
- 19.1.6. Regulatory Bodies
- 19.1.7. Major Associations
- 19.1.8. Taxes Levied
- 19.1.9. Corporate Tax Structure
- 19.1.10. Investments
- 19.1.11. Major Companies
- 19.2. Africa Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
- 19.3. Africa Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
- 19.4. Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 19.5. Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
- 20. Influenza Diagnostics Market Competitive Landscape And Company Profiles
- 20.1. Company Profiles
- 20.2. Abbott Laboratories
- 20.2.1. Company Overview
- 20.2.2. Products And Services
- 20.2.3. Business Strategy
- 20.2.4. Financial Overview
- 20.3. F. Hoffmann-La Roche Ltd
- 20.3.1. Company Overview
- 20.3.2. Products And Services
- 20.3.3. Business Strategy
- 20.3.4. Financial Overview
- 20.4. Becton, Dickinson and Company
- 20.4.1. Company Overview
- 20.4.2. Products And Services
- 20.4.3. Financial Overview
- 20.5. Thermo Fisher Scientific Inc
- 20.5.1. Company Overview
- 20.5.2. Products And Services
- 20.5.3. Business Strategy
- 20.5.4. Financial Overview
- 20.6. Quidel Corporation
- 20.6.1. Company Overview
- 20.6.2. Products And Services
- 20.6.3. Business Strategy
- 20.6.4. Financial Overview
- 21. Key Mergers And Acquisitions In The Influenza Diagnostics Market
- 21.1. Becton, Dickinson and Company Acquired Scanwell Health
- 21.2. Roche Acquired TIB Molbiol Group
- 21.3. Mylab Discovery Solutions Partnered With Hemex Health
- 21.4. Roche Acquired GenMark Diagnostics
- 21.5. Hologic Acquired Mobidiag Oy
- 21.6. DiaSorin Acquired Luminex
- 21.7. Thermo Fisher Acquired Mesa Biotech
- 21.8. Becton Dickinson Acquired NAT Diagnostics
- 21.9. Meridian Bioscience Inc Acquired GenePoc Inc
- 22. Influenza Diagnostics Market Opportunities And Strategies
- 22.1. Global Influenza Diagnostics Market In 2026 – Countries Offering Most New Opportunities
- 22.2. Global Influenza Diagnostics Market In 2026 – Segments Offering Most New Opportunities
- 22.3. Global Influenza Diagnostics Market In 2026 – Growth Strategies
- 22.3.1. Market Trend Based Strategies
- 22.3.2. Competitor Strategies
- 23. Influenza Diagnostics Market, Conclusions And Recommendations
- 23.1. Conclusions
- 23.2. Recommendations
- 23.2.1. Product
- 23.2.2. Place
- 23.2.3. Price
- 23.2.4. Promotion
- 23.2.5. People
- 24. Appendix
- 24.1. Market Data Sources
- 24.2. Research Methodology
- 24.3. Currencies
- 24.4. Research Inquiries
- 24.5. The Business Research Company
- 24.6. Copyright and Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.